Cancer Registry/2007 Primary Site Table
Cancer Registry
Sarasota Memorial’s Cancer Registry follows guidelines established by the National Program of Cancer Registries. The registry tracks every patient treated at Sarasota Memorial and monitors their health throughout his/her lifetime. Cancer registries promote cancer research and successful treatments by:
Patient privacy and confidentiality is maintained at all times.
Primary Site Table
Sarasota Memorial's Cancer Registry makes the following statistics available for cancer research by physicians, scientists and other interested individuals. For assistance or questions, please contact our Cancer Registry manager Nikki Seco at (941) 917-1101 or by email nikki-seco@smh.com.
| PRIMARY SITE TABULATION FOR 2007-ANALYTIC | ||||||||||||
| PRIMARY SITE | TOTAL | CLASS | SEX | AJCC STAGE GROUP | ||||||||
| A | N/A | Male | Female | 0 | I | II | III | IV | UNK | N/A | ||
| ALL SITES | 2148 | 2148 | 0 | 1163 | 985 | 120 | 376 | 659 | 185 | 143 | 507 | 158 |
| ORAL CAVITY | 32 | 32 | 0 | 24 | 8 | 1 | 3 | 3 | 2 | 8 | 15 | 0 |
| LIP | 3 | 3 | 0 | 1 | 2 | 0 | 1 | 0 | 0 | 0 | 2 | 0 |
| TONGUE | 8 | 8 | 0 | 6 | 2 | 0 | 0 | 0 | 0 | 3 | 5 | 0 |
| OROPHARYNX | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| HYPOPHARYNX | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| OTHER | 19 | 19 | 0 | 15 | 4 | 1 | 2 | 3 | 2 | 4 | 7 | 0 |
| DIGESTIVE SYSTEM | 212 | 212 | 0 | 113 | 99 | 4 | 36 | 47 | 30 | 33 | 62 | 0 |
| ESOPHAGUS | 11 | 11 | 0 | 8 | 3 | 0 | 3 | 0 | 1 | 1 | 6 | 0 |
| STOMACH | 9 | 9 | 0 | 7 | 2 | 0 | 2 | 3 | 0 | 1 | 3 | 0 |
| COLON | 103 | 103 | 0 | 53 | 50 | 3 | 20 | 30 | 23 | 14 | 13 | 0 |
| RECTUM | 29 | 29 | 0 | 15 | 14 | 0 | 7 | 6 | 4 | 2 | 10 | 0 |
| ANUS/ANAL CANAL | 4 | 4 | 0 | 2 | 2 | 0 | 0 | 1 | 0 | 1 | 2 | 0 |
| LIVER | 10 | 10 | 0 | 7 | 3 | 0 | 2 | 1 | 0 | 0 | 7 | 0 |
| PANCREAS | 35 | 35 | 0 | 17 | 18 | 0 | 1 | 2 | 1 | 12 | 19 | 0 |
| OTHER | 11 | 11 | 0 | 4 | 7 | 1 | 1 | 4 | 1 | 2 | 2 | 0 |
| RESPIRATORY SYSTEM | 266 | 266 | 0 | 135 | 131 | 1 | 44 | 10 | 36 | 62 | 111 | 2 |
| NASAL/SINUS | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| LARYNX | 13 | 13 | 0 | 8 | 5 | 0 | 3 | 0 | 3 | 0 | 7 | 0 |
| LUNG/BRONCHUS | 249 | 249 | 0 | 127 | 122 | 1 | 41 | 10 | 33 | 61 | 103 | 0 |
| OTHER | 2 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| BLOOD & BONE MARROW | 72 | 72 | 0 | 39 | 33 | 0 | 0 | 0 | 0 | 0 | 1 | 71 |
| LEUKEMIA | 31 | 31 | 0 | 18 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 31 |
| MULTIPLE MYELOMA | 14 | 14 | 0 | 11 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 13 |
| OTHER | 27 | 27 | 0 | 10 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 27 |
| BONE | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| CONNECT/SOFT TISSUE | 14 | 14 | 0 | 8 | 6 | 0 | 2 | 1 | 2 | 1 | 8 | 0 |
| SKIN | 50 | 50 | 0 | 34 | 16 | 5 | 20 | 5 | 2 | 3 | 15 | 0 |
| MELANOMA | 47 | 47 | 0 | 32 | 15 | 5 | 20 | 5 | 2 | 3 | 12 | 0 |
| OTHER | 3 | 3 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 0 |
| BREAST | 354 | 354 | 0 | 4 | 350 | 42 | 131 | 79 | 23 | 4 | 75 | 0 |
| FEMALE GENITAL | 176 | 176 | 0 | 0 | 176 | 19 | 65 | 15 | 28 | 7 | 41 | 1 |
| CERVIX UTERI | 23 | 23 | 0 | 0 | 23 | 2 | 5 | 1 | 1 | 0 | 14 | 0 |
| CORPUS UTERI | 69 | 69 | 0 | 0 | 69 | 0 | 49 | 5 | 5 | 1 | 9 | 0 |
| OVARY | 42 | 42 | 0 | 0 | 42 | 0 | 3 | 7 | 20 | 6 | 5 | 1 |
| VULVA | 36 | 36 | 0 | 0 | 36 | 15 | 6 | 1 | 2 | 0 | 12 | 0 |
| OTHER | 6 | 6 | 0 | 0 | 6 | 2 | 2 | 1 | 0 | 0 | 1 | 0 |
| MALE GENITAL | 612 | 612 | 0 | 612 | 0 | 0 | 2 | 472 | 47 | 7 | 84 | 0 |
| PROSTATE | 607 | 607 | 0 | 607 | 0 | 0 | 0 | 472 | 47 | 7 | 81 | 0 |
| TESTIS | 4 | 4 | 0 | 4 | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 0 |
| OTHER | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| URINARY SYSTEM | 165 | 165 | 0 | 110 | 55 | 48 | 47 | 17 | 9 | 6 | 38 | 0 |
| BLADDER | 96 | 96 | 0 | 72 | 24 | 44 | 19 | 12 | 4 | 6 | 11 | 0 |
| KIDNEY/RENAL | 62 | 62 | 0 | 34 | 28 | 2 | 27 | 4 | 5 | 0 | 24 | 0 |
| OTHER | 7 | 7 | 0 | 4 | 3 | 2 | 1 | 1 | 0 | 0 | 3 | 0 |
| BRAIN & CNS | 43 | 43 | 0 | 17 | 26 | 0 | 0 | 0 | 0 | 0 | 0 | 43 |
| BRAIN (BENIGN) | 4 | 4 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| BRAIN (MALIGNANT) | 20 | 20 | 0 | 11 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 20 |
| OTHER | 19 | 19 | 0 | 4 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 19 |
| ENDOCRINE | 48 | 48 | 0 | 13 | 35 | 0 | 23 | 7 | 3 | 6 | 3 | 6 |
| THYROID | 42 | 42 | 0 | 9 | 33 | 0 | 23 | 7 | 3 | 6 | 3 | 0 |
| OTHER | 6 | 6 | 0 | 4 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| LYMPHATIC SYSTEM | 64 | 64 | 0 | 43 | 21 | 0 | 2 | 3 | 3 | 6 | 50 | 0 |
| HODGKIN'S DISEASE | 3 | 3 | 0 | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 2 | 0 |
| NON-HODGKIN'S | 61 | 61 | 0 | 41 | 20 | 0 | 1 | 3 | 3 | 6 | 48 | 0 |
| UNKNOWN PRIMARY | 34 | 34 | 0 | 10 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 34 |
| OTHER/ILL-DEFINED | 5 | 5 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 4 | 1 |
| Number of cases excluded: 0 | ||||||||||||
| This report INCLUDES CA in-situ cervix cases, squamous and basal cell skin cases, and intraepithelial neoplasia cases | ||||||||||||